1. Anfossi, G., Mularoni, E., Massucco, P., Cavalot, F., Burzacca, S., Mattiello, L., and Trovati, M., Calcium-Channel Blocking Agents Verapamil and Diltiazem Are Inhibitors of Vasopressin-Induced Human Platelet Activation, Clin. Exp. Pharmacol. Physiol., 1991, vol. 18, no. 11, pp. 767–773.
2. Ang, V.T. and Jenkins, J.S., Blood-Cerebral Fluid Barrier to Arginine-Vasopressin, Desmopressin and Desglycinamide Arginine-Vasopressin in the Dog, J. Endocrinol., 1982, vol. 93, no. 3, pp. 319–325.
3. Aravich, P.F. and Sladek, C.D., Vasopressin and Glucopruvic Feeding Behaviour: A New Perspective on An Old Peptide, Brain Res., 1986, vol. 385, no. 2, pp. 245–247.
4. Ashmarin, I.P., Nezavibat’ko, V.N., Myasoedov, N.F., Kamenskii, A.A., Grivennikov, I.A., Ponomareva-Stepnaya, M.A., Andreeva, L.A., Kaplan, A.Ya., Koshelev, V.B., and Ryasina, T.V., Nootropic Analog of Adrenocorticotropin 4-10-Semaks, Zh. vyssh. nerv. deyat., 1997, vol. 47, no. 2, pp. 420–430.
5. Ashmarin, I.P., Karazeeva, E.P., Lyapina, L.A., and Samonina, G.E., The Simplest Proline-Containing Peptides PG, GP, PGP and GPGG: Regulatory Activity and Possible Sources of Biosynthesis, Biokhimiya, 1998, vol. 63, no. 2, pp. 149–155.